Anti-tumor effects of rigosertib in high-risk neuroblastoma-Reference-Cited by-同舟云学术

Anti-tumor effects of rigosertib in high-risk neuroblastoma

Published:2021-08 Issue:8 Volume:14 Page:101149
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Radke Katarzyna,Hansson Karin,Sjölund Jonas,Wolska Magdalena,Karlsson Jenny,Esfandyari Javanshir,Pietras Kristian,Aaltonen Kristina,Gisselsson David,Bexell Daniel

Funder

Swedish Cancer Society

Barncancerfonden

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Neuroblastoma: developmental biology, cancer genomics and immunotherapy [Internet];Cheung;Nat. Rev. Cancer,2013

3. Recent advances in neuroblastoma [Internet];Maris;N. Engl. J. Med.,2010

4. Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer;Karlsson;Nat. Genet.,2018

5. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer;Mengelbier;Nat. Commun.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osmotic Stress Influences Microtubule Drug Response Via WNK1 Kinase Signaling;2024-07-10

2. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy;JCI Insight;2024-05-30

3. Organoids as a new approach for improving pediatric cancer research;Frontiers in Oncology;2024-05-21

4. HDAC6-MYCN-CXCL3 axis mediates allergic inflammation and is necessary for allergic inflammation-promoted cellular interactions;Molecular Immunology;2024-02

5. New Approaches Towards Targeted Therapy for Childhood Neuroblastoma;Anticancer Research;2023-08-30